EFFECTIVE AUGUST 23RD, 2004

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~Pursuant to Section 13 OR 15(d) of The~~ Securities Exchange Act of 1934

~~Date~~Pursuant ofto ~~Report~~Section ~~(Date~~13 ofor ~~earliest event reported~~15(d) ~~September~~ ~~23,~~of ~~2005~~the

~~Canglobe~~Date ~~International~~of ~~Inc.~~report (Date of earliest event reported): October 1, 2007

~~(Exact~~GLOBETECH ~~name~~ENVIRONMENTAL, ~~of registrant as specified in its charter)~~INC.

Nevada	0-27737	77-0454856
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

(Exact name of registrant as specified in Charter)

Suite 700, 300 Fourth Avenue, Las Vegas, Nevada	89101
(Address of principal executive offices)	(Zip Code)

Nevada

0-27737

77-0454856

~~(702~~incorporation or organization) ~~265-1984~~File No.)

~~Registrant’s~~(State ~~telephone~~or ~~number,~~other ~~including~~jurisdiction ~~area~~of ~~code~~(Commission (IRS Employer Identification No.)

~~Suite~~Las ~~2440~~Vegas, ~~10303~~Nevada ~~Jasper Avenue, Edmonton, Alberta Canada T5J 3N6~~89101

#700-300 ~~(Former~~South ~~name~~Fourth ~~or former address, if changed since last report.)~~Street

~~Check~~(Address ~~the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation~~ of ~~the~~Principal ~~registrant~~Executive ~~under any of the following provisions~~ Offices)(~~see~~Zip ~~General Instruction A.2. below~~Code):

~~o Written communications pursuant to Rule 425 under the Securities Act~~ (~~17 CFR 230.425~~403) 261-2929

~~o Soliciting material pursuant to Rule 14a-12 under the Exchange Act~~ (17Issuer ~~CFR~~Telephone ~~240.14a-12~~number)

o(Former ~~Pre-commencement~~name ~~communications~~or ~~pursuant~~former toaddress, ~~Rule~~if ~~14d-2(b)~~changed ~~under~~since ~~the~~last ~~Exchange Act (17 CFR 240.14d-2(b~~report))

oCheck ~~Pre~~the appropriate box below if the Form 8-~~commencement~~K ~~communications~~filing ~~pursuant~~is intended to ~~Rule~~simultaneously ~~13e-4(c)~~satisfy the filing obligations of the registrant under any of the ~~Exchange~~following ~~Act~~provisions (17see ~~CFR~~General ~~240~~Instruction A.~~13e-4(c~~2. below)):

~~INFORMATION~~[ TO] BEWritten ~~INCLUDED~~communications INpursuant ~~THE~~to ~~REPORT~~Rule 425 under the Securities Act (17 CFR 230.425)

~~Section~~[ 1] Soliciting material pursuant to Rule 14a-12 ~~Registrant’s~~under ~~Business~~the ~~and~~Exchange ~~Operations~~Act –(17 ~~not~~CFR ~~applicable~~240.14a-12)

~~Section~~[ 2] Pre-commencement ~~Financial~~communications ~~Information~~pursuant –to ~~not~~Rule ~~applicable~~14d-2(b) under the Exchange Act

~~Section~~(17 3CFR 240.14d- ~~Securities and Trading Markets – not applicable~~2(b))

~~Section~~[ 4] Pre-commencement ~~Matters~~communications ~~Related~~pursuant to ~~Accountants~~Rule ~~and~~13e-4(c) ~~Financial~~under ~~Statements~~the –Exchange ~~not applicable~~Act

~~Section~~(17 5CFR 240.13e- ~~Corporate Governance and Management~~ 4(c))

Item 51.01. ~~Changes~~Entry ininto ~~Control~~a ofMaterial ~~Registrant.~~Definitive Agreement

~~Item~~Tech-Rock/BBR, ~~5.02~~Inc ~~Departure~~Master ofEquipment ~~Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.~~Lease

On November 1, 2007, Globetech Environmental, Inc. (the “Company”) entered into a Master Equipment Lease Agreement with Tech-Rock LLC and BBR, Inc pursuant to which the Company sold for $875,000, one Globetech GT500 machine that is expected to be placed in service by March 2008 and agreed to lease that machine with the intent of sub-leasing the machines to third-party end users. Pursuant to the Master Equipment Lease Agreement, the Company agreed to lease the machine for lease payments of $14,600 per month for a period of 120 months commencing on the earlier of (i) installation of each machine at the site of a third-party end user or (1ii) ~~Director~~March ~~resignations:~~1, 2008.

~~(i)~~MediVac ~~James~~Manufacturing ~~Baker resigned as a director on August 19, 2005~~ and ~~David~~License ~~Alexander resigned as a director September 9, 2005;~~Agreement

~~(ii)~~On ~~David~~December ~~Alexander~~1, 2007, the Company and MediVac Limited agreed to terminate their March 28, 2007 Joint Venture Agreement and to enter into Licensing Agreements. The agreements will permit each company to market the other’s ~~Chief~~product ~~Financial~~line ~~Officer~~in ~~and~~stipulated ~~Secretary~~geographic ~~resigned~~areas onfor ~~September~~a 9,designated ~~2005;~~period of time. The Company will also assume the manufacturing of all of MediVac’s Metamizer units sold by the Company and MediVac on a cost plus 20% basis.

~~(iii)~~Item ~~The~~1.02. ~~resignations~~Termination ~~were~~of bya ~~agreement.~~Material Definitive Agreement

~~(b)~~Logmed ~~Both~~/ ~~Mr. Baker~~Goldner ~~and Mr. Alexander resigned by agreement~~Agreement

Effective October 31, 2007, Helmut Goldner unilaterally terminated the Purchase and Sale Agreement pursuant to which the Company had previously acquired the rights to the intellectual property and patents pertaining to Logmed. Goldner’s termination of the agreement was triggered by the Company withholding the € 100,000 (cEuro) payment that was due September 30, 2007. The Company withheld this payment in an effort to address the ongoing failure of Mr. ~~Theodor~~Goldner ~~Henneg~~to ~~will~~perform ~~become~~certain ~~Chief~~obligations ~~Financial~~under ~~Officer~~the ~~and~~agreement. ~~Secretary~~The asCompany had attempted to renegotiate the terms of ~~September~~the 25agreement to reflect the defaults by Mr. Golder but was unable to arrive at a satisfactory resolution. As a result of the termination, ~~2005:~~all Logmed intellectual property and patents reverted to Mr. Goldner, $1,325,000 (€ 900,000 Euro) in remaining payments to Goldner are eliminated and the Company will retain ownership and continue to operate Logmed Technologie GmbH as its European subsidiary and base of operations.

~~(d) Mr. Theodor~~MediVac ~~will~~Joint ~~become~~Venture ~~a Director as of September 25, 2005~~Agreement

See Item 51.0301 ~~Amendments~~– toMediVac ~~Articles~~Manufacturing ofand ~~Incorporation~~License orAgreement, ~~Bylaws; Change in Fiscal Year – not applicable~~above.

Item 52.0403. ~~Temporary~~Creation ~~Suspension~~ of ~~Trading~~a ~~Under~~Direct ~~Registrant’s~~Financial ~~Employee~~Obligation ~~Benefit~~or ~~Plans~~an –Obligation ~~not~~under ~~applicable~~an Off-Balance

~~Item~~Sheet ~~5.05~~Arrangement ~~Amendments to the Registrant’s Code~~ of ~~Ethics, or Waiver of~~ a ~~Provision of the Code of Ethics – not applicable~~Registrant

~~Section~~See 6Item -1.01 ~~[Reserved]~~– ~~not~~MedRock ~~applicable~~Master Equipment Lease, above.

~~Section 7 - Regulation FD – not applicable~~2

~~Section~~Item 83.02. -Unregistered ~~Other~~Sales ~~Events~~of –Equity ~~not applicable~~Securities

~~Section~~On 9November -7, ~~Financial~~2007, ~~Statements~~the Company raised $100,000 through the issuance to a single accredited investor, of an 8.5% one year convertible debenture and ~~Exhibits-~~a ~~not~~warrant ~~applicable~~to acquire 1 million shares of common stock. Interest on the debenture is payable quarterly and the debenture is convertible at the greater of $.05 per share or market. The warrant is exercisable for a period of two years at an exercise price of $.10 per share. No commissions or fees were paid in connection with this transaction.

~~SIGNATURES~~On December 14, 2007, the Company issued a total of 750,000 shares of common stock and a warrant to acquire 750,000 shares of common stock to a single accredited investor for $30,000 paid in cash. No commissions or fees were paid in connection with the issue of the above shares.

~~Pursuant~~All of the securities described above were issued pursuant to the ~~requirements~~exemption from registration provided by Section 4(2) of the Securities ~~Exchange~~ Act of ~~1934,~~1933. The issuances were privately negotiated with each of the ~~registrant~~purchasers ~~has~~and ~~duly~~with ~~caused~~no ~~this~~general ~~report~~solicitation toor bepublic ~~signed~~advertising onand ~~its~~the ~~behalf~~certificates byevidencing the ~~undersigned~~securities ~~hereunto~~issued ~~duly~~bear ~~authorized~~restrictive legends.

~~CANGLOBE~~Item ~~INTERNATIONAL INC~~5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment

~~(Registrant)~~of Certain Officers; Compensatory Arrangements of Certain Officers.

Date: September 23, 2005	_s/ Donald Sampson
	Donald Sampson
	Director/President
	_s/Theodor Hennig
	Theodor Hennig
	Director/Chief Financial Officer

On October 1, 2007, the Company entered into a Consulting Agreement with Theodor Hennig Professional Corporation (“THPC”) pursuant to which THPC agreed to continue providing accounting, tax and financial advisory services, and serve as Chief Financial Officer, for a period of fifteen months commencing October 1, 2007. Under the terms of the Consulting Agreement, the Company agreed to pay to THPC CDN$10,000 per month and to pay a bonus equal to 2% of EBITDA.

Item 9.01. Financial Statements and Exhibits.

(c)

Exhibits

10.1 Manufacturing and License Agreement, dated November 11, 2007, between Globetech Environmental, Inc. and MediVac Limited

10.2 Consulting Agreement, dated October 1, 2007, between Globetech Environmental, Inc. and Theodor Hennig Professional Corporation

10.3

Form of 8.5% Convertible Debenture, dated November 2007

10.4

Purchase Agreement with Sridhar Ramachandran

10.5

Form of two year $0.08 Warrant, dated December 2007

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

GLOBETECH ENVIRONMENTAL, INC.

Dated: December 18, 2007

By:

/s/ Theodor Hennig

Theodor Hennig

Chief Financial Officer

Filing Compare · GlobalGold Corp